Clinical Trial Update: PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating a PD-1 antibody for dMMR/MSI-H stage III colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Carcinoma | Phase 3 | Status: RECRUITING